Cargando…
Pediatric Parapneumonic Empyema, Spain
Pediatric parapneumonic empyema (PPE) has been increasing in several countries including Spain. Streptococcus pneumoniae is a major PPE pathogen; however, antimicrobial pretreatment before pleural fluid (PF) sampling frequently results in negative diagnostic cultures, thus greatly underestimating th...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2603109/ https://www.ncbi.nlm.nih.gov/pubmed/18760005 http://dx.doi.org/10.3201/eid1409.071094 |
_version_ | 1782162562600665088 |
---|---|
author | Obando, Ignacio Muñoz-Almagro, Carmen Arroyo, Luis A. Tarrago, David Sanchez-Tatay, David Moreno-Perez, David Dhillon, Sahar S. Esteva, Cristina Hernandez-Bou, Susanna Garcia-Garcia, Juan J. Hausdorff, William P. Brueggemann, Angela B. |
author_facet | Obando, Ignacio Muñoz-Almagro, Carmen Arroyo, Luis A. Tarrago, David Sanchez-Tatay, David Moreno-Perez, David Dhillon, Sahar S. Esteva, Cristina Hernandez-Bou, Susanna Garcia-Garcia, Juan J. Hausdorff, William P. Brueggemann, Angela B. |
author_sort | Obando, Ignacio |
collection | PubMed |
description | Pediatric parapneumonic empyema (PPE) has been increasing in several countries including Spain. Streptococcus pneumoniae is a major PPE pathogen; however, antimicrobial pretreatment before pleural fluid (PF) sampling frequently results in negative diagnostic cultures, thus greatly underestimating the contribution of pneumococci, especially pneumococci susceptible to antimicrobial agents, to PPE. The study aim was to identify the serotypes and genotypes that cause PPE by using molecular diagnostics and relate these data to disease incidence and severity. A total of 208 children with PPE were prospectively enrolled; blood and PF samples were collected. Pneumococci were detected in 79% of culture-positive and 84% of culture-negative samples. All pneumococci were genotyped by multilocus sequence typing. Serotypes were determined for 111 PPE cases; 48% were serotype 1, of 3 major genotypes previously circulating in Spain. Variance in patient complication rates was statistically significant by serotype. The recent PPE increase is principally due to nonvaccine serotypes, especially the highly invasive serotype 1. |
format | Text |
id | pubmed-2603109 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-26031092009-01-13 Pediatric Parapneumonic Empyema, Spain Obando, Ignacio Muñoz-Almagro, Carmen Arroyo, Luis A. Tarrago, David Sanchez-Tatay, David Moreno-Perez, David Dhillon, Sahar S. Esteva, Cristina Hernandez-Bou, Susanna Garcia-Garcia, Juan J. Hausdorff, William P. Brueggemann, Angela B. Emerg Infect Dis Research Pediatric parapneumonic empyema (PPE) has been increasing in several countries including Spain. Streptococcus pneumoniae is a major PPE pathogen; however, antimicrobial pretreatment before pleural fluid (PF) sampling frequently results in negative diagnostic cultures, thus greatly underestimating the contribution of pneumococci, especially pneumococci susceptible to antimicrobial agents, to PPE. The study aim was to identify the serotypes and genotypes that cause PPE by using molecular diagnostics and relate these data to disease incidence and severity. A total of 208 children with PPE were prospectively enrolled; blood and PF samples were collected. Pneumococci were detected in 79% of culture-positive and 84% of culture-negative samples. All pneumococci were genotyped by multilocus sequence typing. Serotypes were determined for 111 PPE cases; 48% were serotype 1, of 3 major genotypes previously circulating in Spain. Variance in patient complication rates was statistically significant by serotype. The recent PPE increase is principally due to nonvaccine serotypes, especially the highly invasive serotype 1. Centers for Disease Control and Prevention 2008-09 /pmc/articles/PMC2603109/ /pubmed/18760005 http://dx.doi.org/10.3201/eid1409.071094 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Obando, Ignacio Muñoz-Almagro, Carmen Arroyo, Luis A. Tarrago, David Sanchez-Tatay, David Moreno-Perez, David Dhillon, Sahar S. Esteva, Cristina Hernandez-Bou, Susanna Garcia-Garcia, Juan J. Hausdorff, William P. Brueggemann, Angela B. Pediatric Parapneumonic Empyema, Spain |
title | Pediatric Parapneumonic Empyema, Spain |
title_full | Pediatric Parapneumonic Empyema, Spain |
title_fullStr | Pediatric Parapneumonic Empyema, Spain |
title_full_unstemmed | Pediatric Parapneumonic Empyema, Spain |
title_short | Pediatric Parapneumonic Empyema, Spain |
title_sort | pediatric parapneumonic empyema, spain |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2603109/ https://www.ncbi.nlm.nih.gov/pubmed/18760005 http://dx.doi.org/10.3201/eid1409.071094 |
work_keys_str_mv | AT obandoignacio pediatricparapneumonicempyemaspain AT munozalmagrocarmen pediatricparapneumonicempyemaspain AT arroyoluisa pediatricparapneumonicempyemaspain AT tarragodavid pediatricparapneumonicempyemaspain AT sancheztataydavid pediatricparapneumonicempyemaspain AT morenoperezdavid pediatricparapneumonicempyemaspain AT dhillonsahars pediatricparapneumonicempyemaspain AT estevacristina pediatricparapneumonicempyemaspain AT hernandezboususanna pediatricparapneumonicempyemaspain AT garciagarciajuanj pediatricparapneumonicempyemaspain AT hausdorffwilliamp pediatricparapneumonicempyemaspain AT brueggemannangelab pediatricparapneumonicempyemaspain |